Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
18 Results for "
tumor-related diseases
" in MedChemExpress (MCE) Product Catalog:
Products (18)
18 Results for "tumor-related diseases" in MCE Product Catalog:
2
Target:
Research Areas:
Fludarabine-Cl has an inhibitory effect on RNA adenosine deaminase 1 (ADAR1) with an IC50 of 0.87 μM and can be used to prevent and/or study cancer or tumor-related diseases .
1
Category:
Infection Triterpenes Animals Terpenoids Marine natural products Other marine organisms Disease Research Fields Cancer
Target:
1
Category:
Other disease Metabolic Disease Endogenous metabolite Human Gut Microbiota Metabolites Flavonoids Isoflavanones Disease markers Phenols Polyphenols Disease Research Fields
Target:
Cat. No.: HY-N1465
CAS No.: 17413-38-6
Synonyms: Aristolochic acid-IVa
Cat. No.: HY-141662
CAS No.: 2586047-11-0
Target:
Research Areas:
2’,3’-cGAMP-C2-PPA is a cyclic dinucleotide interferon gene-stimulating protein (STING) agonist. 2’,3’-cGAMP-C2-PPA is a drug conjugated conjugate used to target antibody-drug conjugated conjugate (ADC) for the treatment of cancer. 2’,3’-cGAMP-C2-PPA can be used in the study of immune and tumor-related diseases .
Cat. No.: HY-129361
CAS No.: 1834516-06-1
Target:
Research Areas:
Fmoc-Ala-Ala-Asn-PABC-PNP is a peptide-based linker intermediate composed of Fmoc-protected Ala-Ala-Asn, PABC, and PNP. Fmoc-Ala-Ala-Asn-PABC-PNP can be used to prepare Auristatin antibody-drug conjugates (ADCs). Fmoc-Ala-Ala-Asn-PABC-PNP is applicable to tumor-related research .
Cat. No.: HY-147590
CAS No.: 2766565-88-0
Target:
Research Areas:
CD73-IN-9 (compound 2) is a potent inhibitor of CD73. CD73 can catalyze the production of adenosine from extracellular 5'-phosphate adenosine (5'-AMP), and adenosine can induce immunosuppressive effects and promote tumor proliferation and/or metastasis. CD73-IN-9 can be used for the study of tumor-related diseases .
Cat. No.: HY-147594
CAS No.: 2773423-69-9
CD73-IN-13 (compound 7) is a potent inhibitor of CD73. CD73 is closely associated with tumor growth, angiogenesis and metastasis. CD73-IN-13 can be used for the study of tumor-related diseases .
Cat. No.: HY-147588
CAS No.: 2763709-14-2
CD73-IN-7 (compound 13) is a potent inhibitor of CD73. CD73 can catalyze the production of adenosine from extracellular 5'-phosphate adenosine (5'-AMP), and adenosine can induce immunosuppressive effects and promote tumor proliferation and/or metastasis. CD73-IN-7 can be used for the study of tumor-related diseases .
Cat. No.: HY-147589
CAS No.: 2763710-08-1
CD73-IN-8 (compound 57) is a potent inhibitor of CD73. CD73 can catalyze the production of adenosine from extracellular 5'-phosphate adenosine (5'-AMP), and adenosine can induce immunosuppressive effects and promote tumor proliferation and/or metastasis. CD73-IN-8 can be used for the study of tumor-related diseases .
Cat. No.: HY-147591
CAS No.: 2766565-91-5
Target:
Research Areas:
CD73-IN-10 (compound 4) is a potent inhibitor of CD73. CD73 can catalyze the production of adenosine from extracellular 5'-phosphate adenosine (5'-AMP), and adenosine can induce immunosuppressive effects and promote tumor proliferation and/or metastasis. CD73-IN-10 can be used for the study of tumor-related diseases .
Cat. No.: HY-147592
CAS No.: 2766566-11-2
Target:
Research Areas:
CD73-IN-11 (compound 24) is a potent inhibitor of CD73. CD73 can catalyze the production of adenosine from extracellular 5'-phosphate adenosine (5'-AMP), and adenosine can induce immunosuppressive effects and promote tumor proliferation and/or metastasis. CD73-IN-11 can be used for the study of tumor-related diseases .
Cat. No.: HY-147593
CAS No.: 2773502-79-5
CD73-IN-12 (compound 9) is a potent inhibitor of CD73. CD73 is closely associated with tumor growth, angiogenesis and metastasis. CD73-IN-12 can be used for the study of tumor-related diseases . CD73-IN-12 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Cat. No.: HY-N1461R
CAS No.: 17238-05-0
Synonyms: (±)-Dihydrodaidzein (Standard)
Cat. No.: HY-N1465R
CAS No.: 17413-38-6
Synonyms: Aristolochic acid-IVa (Standard)
Cat. No.: HY-155577
CAS No.: 2927489-95-8
Target:
Research Areas:
MAO A/HSP90-IN-1 (4-b) is a MAO A/HSP90 dual inhibitor with IC50 value of 1.77 μM and 0.019 μM in Glioblastoma (GBM) GL26 cells and HSP90α, respectively. MAO A/HSP90-IN-1 (4-b) can inhibit MAO A activity, HSP90 binding and the expression of HER2 and phospho-Akt to inhibit the growth of GBM, they also reduce PD-L1 expression, which inhibits T cell activation. MAO A/HSP90-IN-1 (4-b) have potential to inhibit tumor immune escape. MAO A/HSP90-IN-1 (4-b) can be used for brain tumor-related diseases research .
Cat. No.: HY-W540123
CAS No.: 186046-82-2
Target:
Research Areas:
Cat. No.: HY-P11698
CAS No.: 476667-31-9
Research Areas:
- 1
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
